Kubotech Co., Ltd., a dental medical device company, announced on the 20th that it had selected KB Securities as the lead manager for its initial public offering (IPO). Kubotech plans to reorganize its internal organization and begin preparing for the public offering with the goal of listing on KOSDAQ in 2027.
Kubotek has about 70 dentists as shareholders based on trust in its implant technology, and in August 2024, it received an investment of 2 billion won from Bright Asset Management, an IPO specialist management company.
Kubotek is also developing innovative products such as new concept 3D printing implants and alkaline silicate 3D printing prosthesis materials targeting the next-generation implant market. In July of last year, it was selected for the Ministry of Trade, Industry and Energy's '2024 Material and Component Technology Development Project' national project, and plans to continue technology development by receiving 2.5 billion won in government subsidies until 2026. Through this, it plans to advance domestic implant technology and further strengthen the company's competitiveness.
Kubotek is also actively pursuing overseas market development. It has already obtained European approval and achieved success in Eastern Europe with Poland as its base, and is exporting to 16 countries including the Middle East, Southeast Asia, Central and South America, and Africa. It is also pursuing approval procedures for entering the North American and Chinese markets, and plans to continuously expand its global business with the goal of expanding overseas sales channels.
Jeong Cheol-ung, CEO of Kubotek, said, “Through the KOSDAQ listing, we will further accelerate R&D, expansion of production facilities, and expansion into overseas markets, and create new growth engines for the company.” He added, “Based on innovative technologies and highly functional products, we will grow into a leading next-generation dental materials and implant company.”
You must be logged in to post a comment.